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E-mail address: ssalim@uh.edu (S. Salim).Regulator of G-protein signaling protein (RGS)-2 is a modulator of anxiety and dysregulation of oxi-
dative stress is implicated in anxiety. Also, RGS2 expression is reported to be induced by oxidative
stress. Thus, if oxidative stress induces RGS2 expression and lack of RGS2 causes anxiety, then mech-
anisms that link RGS2 and oxidative stress potentially critical to anxiety must be revealed. Our study
is the ﬁrst to suggest role of RGS2 in regulation of enzymes involved in antioxidant defense namely
glyoxalase-1 and glutathione reductase-1 via activation of p38 MAPK and PKC pathways in an Sp-1
dependent manner.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction if oxidative stress induces RGS2 expression and lack of RGS2 causesWe recently reported that increasing oxidative stress in the
brain by pharmacological intervention [L-Buthionine-(S,R)-sulfox-
imine (BSO) treatment], increased anxiety-like behavior of rats.
Interestingly, treatment with the antioxidant, tempol, reduced oxi-
dative stress and attenuated anxiety-like behavior of rats [1]. These
ﬁndings were replicated with another oxidative stress inducer,
xanthine and xanthine oxidase [2]. Quite recently, two enzymes,
glyoxalase (GLO)-1 and glutathione reductase (GSR)-1 involved in
antioxidant defense were implicated to play an important role in
anxiety [3]. Overall, the concept of involvement of oxidative stress
in anxiety disorders is achieving consensus [4,5]. Interestingly, reg-
ulator of G-protein signaling protein (RGS)-2 gene is associated
with anxiety in animal models and in humans. RGS2 knockout
mice are reported to be anxious [6,7]. There also is evidence for a
linkage between RGS2 and anxiety disorder proneness and associ-
ation of polymorphisms in RGS2 with panic disorder in humans [8]
as well as an association between polymorphisms in RGS2 gene
and anxiety-related temperament, personality, and processing of
emotional information in the brain [9]. Moreover, RGS2, classically
known to regulate G-protein signaling [10], is also reported to be
induced by acute oxidative stress in cell culture [11]. Therefore,lf of the Federation of European Bi
ng protein (RGS)-2; LC, locusanxiety, then mechanisms that link RGS2 and oxidative stress must
be revealed. This might shed new light on mechanisms potentially
relevant to the pathophysiology of anxiety disorders.
Utilizing a neuronal cell line derived from locus coeruleus (LC),
we investigated regulation of RGS2, GSR1 and GLO1 in response to
oxidative stress by focusing on two pathways, Protein Kinase C
(PKC) and p38 MAPK. Our logic for focusing on these pathways is
the following. First, oxidative stress is reported to activate PKC
[12]. Second, RGS2 is reported to be induced by acute oxidative
stress [11]. Third, is the reported involvement of p38 pathway in
regulation of RGS2 mRNA expression [13,14]. Thus role of these
two pathways in regulation of enzymes involved in antioxidant de-
fense namely GLO1 and GSR1 via an RGS2 dependent mechanism
were examined in CATH.a cells.
2. Material and methods
2.1. Material
The following were purchased from the indicated sources
Hydrogen peroxide (H2O2): Sigma Chemical Co., St. Louis, MO;
fetal bovine serum and penicillin–streptomycin: Atlanta Biological,
Norcross, GA; RNeasy Mini kit cat# 74104: Qiagen; Superscript one
step RT-PCR kit cat# 11922-028: Invitrogen life technologies; Ethi-
dium bromide cat# H5041, molecular ruler cat# 170-8202 and
SDS-PAGE marker cat# 161-0324: Biorad. Anti-Sp-1, P-p38, p38
and RGS2 and horse-radish peroxidase conjugated anti-rabbitochemical Societies.
1376 S. Salim et al. / FEBS Letters 585 (2011) 1375–1381secondary antibodies: Santa Cruz Biotechnology Inc. Santa Cruz,
CA. CATH.a cells #CRL-11179™: ATCC, VA.
2.2. Malondialdehyde assay (MDA) and protein carbonylation
CATH.a cells were treated with vehicle/H2O2/BSO, processed
and quantiﬁed for MDA as described [2,15]. Protein carbonylation
was conducted using OxiSelect Protein Carbonyl ELISA kit (#STA-
310, Cell Biolabs Inc. USA) per manufacturer’s instructions.
2.3. Western blotting
Cells were washed with PBS, lysed, protein concentration deter-
mined in lysates [16] and subjected to western blotting [17].
2.4. PKC activity
PKC activity was measured according to manufacturer’s proto-
col (catalog# V5330; Promega Corporation, Madison, WI) as previ-
ously published by us [18].
2.5. Semiquantitative and quantitative (Q) RT-PCR
Total RNA was isolated from CATH.a cells after vehicle/H2O2 or
BSO treatment and semiquantitative RT-PCR carried out as previ-
ously published [17] using oligonucleotide primers speciﬁc for
each RGS [19]. Q-RT-PCR measurements were done on a 7300 Real
Time PCR system (Applied Biosytems) using TaqManR one-step RT-
PCR kit (# 4309169) with pre-designed TaqMan forward and re-
verse primers obtained from Applied Biosystems Foster City, CA,
for mouse RGS2 (ID# Mm00501385_m1), RGS4 (ID#
Mm00501389_m1), GLO1 (ID# Mm00844954_s1), GSR1 (ID#
Mm00833903_m1) and GAPDH primers (ID# Mm99999915_g1).
Standard curves were run with serial dilutions of RNA and the
PCR efﬁciencies determined for all oligo sets.
2.6. Transient transfection
For antisense experiments, CATH.a cells (50–60% conﬂuent)
were transiently transfected using FuGENE6 reagent (Invitrogen)
with random (50-GCCTTATTTACTACTTTCGC-30) or RGS2 antisense
(50-GCTGAATTCAAGGTC-30) oilgonucleotides. 48 h later, cells were
harvested and subjected to Q-RTPCR or western blotting. For lucif-
erase assays, CATH.a cells (60% conﬂuent) were transiently trans-
fected using effectene reagent with wild type or mutant RGS2
promoter luciferase construct (1.0 lg DNA/well) as well as renilla
construct (0.1 lg). Renilla is a control for transfection efﬁciency.
24 h later, the cells were treated with H2O2/vehicle (100 lM) or
BSO/vehicle (1 mM) for 1 h. The treatment was terminated by
addition of phosphate-buffered saline. The cells were then har-
vested (Promega #E1910) and lysates used for luciferase assay
(Promega #E1910) and bioluminescence measured on Wallac Vic-
tor2 1420 Counter. Luciferase luminescence was normalized to
renilla luminescence and the ratio thus obtained was normalized
to total protein.
2.7. Immunoﬂuorescence
CATH.a cells were grown on poly D-lysine coated glass cover
slips to 40–70% conﬂuence and exposed to vehicle/H2O2
(100 lM) for 1 h and processed as previously published by us
[17]. The cells were incubated with anti-Sp-1 or anti-RGS2 anti-
body overnight at 4 C, followed by cy3-conjugated secondary anti-
body for 1 h in dark. As a negative control we stained the cells
either with primary or secondary antibody alone.2.8. Data analysis
Data are expressed as mean ± S.E.M. Comparisons between
groups were made either by Student’s t-test or one way ANOVA
followed by Tukey’s post-hoc test where appropriate (GraphPad
Software, Inc. San Diego, CA), and groups were considered signiﬁ-
cantly different if P < 0.05.
3. Results
We examined the effect of H2O2 (a direct oxidant, 100 lM) and
BSO (a pro-oxidant drug, 1mM) treatment on oxidative stress
markers including protein carbonylation and malondialdehyde
(MDA) in CATH.a cells. Both H2O2 and BSO signiﬁcantly increased
protein carbonylation (Fig. 1A) and MDA (Fig. 1B) with increasing
time as compared to vehicle treated cells. H2O2 caused 123% in-
crease in protein carbonylation and 240% increase in MDA at
0.5 h and 207% increase in carbonylation and 280% increase in
MDA at 1 h. BSO resulted in 174% increase in protein carbonylation
and 260% increase in MDA at 0.5 h and 300% increase in carbonyls
and 730% increase in MDA at 1 h. Minimum cell death or morpho-
logical deterioration was noted at the dose of H2O2 or BSO used
(Fig. 1C,D). Cell viability was detected at 91–94% with either treat-
ment. Next, mRNA expression of several RGS proteins in CATH.a
cells were examined using semi-quantitative RT-PCR with speciﬁc
primers for each RGS protein (Fig. 2A). It appears that only RGS2
mRNA levels increased upon H2O2 (100 lM for 1 h) or BSO (1mM
for 1 h) treatment (Fig. 2B). This was conﬁrmed using quantita-
tive-RTPCR which also indicate that RGS2 mRNA levels are signiﬁ-
cantly upregulated in response to induction of oxidative stress via
both, H2O2 (+200%) or BSO (+300%) treatment as compared to vehi-
cle treated controls (Fig. 3A). The related RGS protein, RGS4 mRNA
expression remained unchanged in response to both H2O2 and BSO
(Fig. 3B). We also examined the effect of H2O2 and BSO treatment
on mRNA expression of GLO1 and GSR1. A signiﬁcant increase in
GLO1 (+300%: H2O2; +310%: BSO) and GSR1 (+333%: H2O2;
+280%: BSO) mRNA expression was observed (Fig. 3A).
Furthermore, CATH.a cells were transfected with RGS2 anti-
sense or random oligonucleotides (2.5 mM) and cells treated with
vehicle/H2O2 (100 lM) for 1 h. RGS2 antisense treatment resulted
in a signiﬁcant decrease in H2O2-induced GLO1 (181%) and
GSR1 (300%) mRNA expression as compared to random oligonu-
cleotide treated vehicle or H2O2 samples (Fig. 4A). Random RGS2
oligo treatment had no effect on H2O2-induced RGS2, GLO1 and
GSR1 mRNA expression suggesting speciﬁcity for RGS2 antisense
oligos. Moreover, H2O2-induced GLO1 and GSR1 protein expression
also was signiﬁcantly reduced (140%, 200% respectively) when
compared to random oligonucleotide transfected vehicle controls
(Fig. 4B,C). Protein expression of two other antioxidant enzymes,
superoxide dismutase (SOD) and catalase (CAT) remained un-
changed with H2O2 or with RGS2 antisense treatment (Fig. 4D,E).
Induction of oxidative stress caused activation of PKC deter-
mined in CATH.a cell lysates treated with H2O2 (100 lM). PKC
activity was signiﬁcantly increased by 50% after 15 min of H2O2
treatment as compared to vehicle treated samples. The activation
however was noted maximum at 1 h of H2O2 treatment (+210%)
(Fig. 5A). Nuclear translocation of transcription factor, Sp-1 also
was determined in response to H2O2 (100 lM, 1h) treatment. We
observed that H2O2 treatment resulted in translocation of Sp-1
from the cytosol to the nucleus (Fig. 5B). In vehicle-treated cells,
Sp-1 (red signal) was dispersed throughout the cytosol with almost
no nuclear localization (blue signal) (Fig. 5B). In cells treated with
H2O2, the intensity of the Sp-1 signal in the nuclei increased dra-
matically, staining the entire nucleus red. Moreover, as nuclear
localization of Sp-1 increased, the Sp-1 signal disappeared from
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Fig. 1. Measurement of oxidative stress and examination of cell viability and morphology. CATH.a cells were treated with vehicle or 100 lM H2O2 or 1 mM BSO for 30 and
60 min. MDAwas quantiﬁed using molar extinction coefﬁcient 1.56  105 M/cm [1,2]. Protein carbonylation was measured using an ELISA based assay (Cell Biolabs Inc., USA).
⁄Signiﬁcantly different from respective vehicle, P < 0.05, N = 4. Cell viability was measured using trypan blue exclusion method. CATH.a cells were treated with vehicle/H2O2/
BSO as before, harvested by trypsinization, stained with trypan blue and counted using a haemocytometer. Cell viability was expressed as percentage of excluded divided by
total number of cells. N = 3. Cell morphology was examined using Olympus 1X81 Fluorescence Deconvolution Microscope System under bright ﬁeld (phase contrast setting).
Shown is a representative area of cells at the indicated treatment.
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Fig. 2. Effect of H2O2 or BSO treatment on mRNA expression of RGS proteins in CATH.a cells. Total RNA was isolated from CATH.a cells, reverse transcribed and ampliﬁed with
primers for speciﬁc RGS proteins [19] using semiquantitative-RT-PCR [17] (A). CATH.a cells were treated with vehicle (V), H2O2 , (100 lM:H) or BSO (1 mM:B) for 1 h, RNA was
isolated and reverse transcribed using RTPCR (B). PCR products were electrophoresed on a 2% agarose gel, stained with 0.5 lg/ml ethidium bromide, and visualized under UV.
A molecular ruler (100–3000 bp) on the left-hand side of the gel is used for reference.
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Fig. 3. H2O2 or BSO treatment increases mRNA expression of RGS2, GLO1 and GSR1 in CATH.a cells. CATH.a cells were treated with H2O2 (100 lM) or BSO (1 mM) for 1 h and
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used in PCR reaction was 50 ng. GAPDH was used as an internal control. ⁄Signiﬁcantly different from respective vehicle, P < 0.05, N = 6.
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1378 S. Salim et al. / FEBS Letters 585 (2011) 1375–1381the cytosol. Similar results were obtained for BSO (data is shown
for H2O2 only). We also detected increased Sp-1 protein accumula-
tion in nuclear extracts of CATH.a cells treated with H2O2 as com-
pared to vehicle-treated cells. Nuclear accumulation of Sp-1
proteins was increased by 80% (expressed as percentage of con-
trol) (Fig. 5C). PKC activation also resulted in nuclear translocation
(Fig. 5D) and nuclear accumulation of RGS2 (Fig. 5E). A consider-
able amount of RGS2 protein was detected at the basal level in
the nuclei.Furthermore, H2O2 treatment (100 lM) signiﬁcantly activated
p38 MAPK pathway at 15 min detected via western blotting
wherein H2O2 treatment signiﬁcantly increased (+100%) phos-
pho-p38 protein expression (normalized to total protein) in CATH.a
cells. This activation was sustained until 4 h of H2O2 treatment
(Fig. 6A). p38 MAPK activity is measured as an index of its phos-
phorylation. H2O2-induced increase in p38 MAPK phosphorylation
was prevented when cells were pretreated with p38 MAPK inhibi-
tor, SB203580 (cat# 559389, EMD4Biosciences, USA, 25 lM, 1 h).
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present during H2O2 incubation (Fig. 6B). Thus, our treatmentconditions sufﬁciently block H2O2-induced p38 activation.
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other MAPK proteins (phospho and total ERK1/2) were not altered
(data not shown). Furthermore, activation of p38 signiﬁcantly in-
creased mRNA expression of RGS2 (+340%) and pretreatment ofcells with the p38 inhibitor prevented the increase in RGS2 expres-
sion. RGS4 mRNA expression remained unchanged (Fig. 7A). Inter-
estingly, H2O2-induced increase in GLO1 and GSR1 mRNA
expression also is prevented with SB203580 or with PKC inhibitor,
chelethyrine chloride (CC) (10 lM, 2 h) treatment (Fig. 7B). The le-
vel of GLO1 and GSR1 mRNA expression is reduced further when
cells were treated with SB203580 and CC in combination.
Finally, the wild type RGS2 promoter [20] exhibited increased
luciferase activity while the mutant RGS2 promoter [20] in which
Sp-1 site is mutated, remained unresponsive to H2O2 or BSO treat-
ment and failed to increase luciferase activity. Pretreatment with
p38 inhibitor, SB203580 inhibited BSO or H2O2 induced RGS2 pro-
moter activity (Fig. 8). Similar results were obtained in BE(2)-C
cells, a human neuroblastoma cell line.
4. Discussion
In this study, RGS2 mRNA levels were selectively and signiﬁ-
cantly upregulated in response to H2O2 or BSO-induced oxidative
stress in CATH.a cells. Interestingly, both mRNA and protein levels
of GLO1 and GSR1 also increased with induction of oxidative stress.
Furthermore, pretreatment of CATH.a cells with RGS2 antisense,
attenuated H2O2-induced increase in GLO1 and GSR1 levels.
Expression of two other antioxidant enzymes, CAT and SOD re-
mained unchanged. It seems reasonable to suggest that upregula-
tion of GLO1 and GSR1 expression in response to oxidative stress
is quite possibly an RGS2-dependent event as reducing RGS2
expression by antisense treatment prevented the increase in
GLO1 and GSR1 mRNA and protein expression. Whether GLO1
and GSR1 can be considered as potential transcriptional targets
of RGS2 remains to be validated in future.
Our study suggests that increase in RGS2 expression is
p38-dependent while transcriptional activation of GLO1 and
S. Salim et al. / FEBS Letters 585 (2011) 1375–1381 1381GSR1 appears to require simultaneous activation of both p38 and
PKC pathways. This becomes clear from the observation that
H2O2 or BSO-induced oxidative stress increased mRNA expression
of RGS2 while pretreatment with p38 inhibitor prevents this in-
crease. Increase in GLO1 and GSR1 mRNA upon induction of oxida-
tive stress is signiﬁcantly reduced with p38 inhibitor treatment.
Pretreatment of CATH.a cells with PKC inhibitor, chelethyrine chlo-
ride (CC) also prevents H2O2-induced increase in GLO1 and GSR1
but RGS2 mRNA expression remains unchanged. In the presence
of both inhibitors, SB203580 and CC, H2O2-induced increase in
GLO1 and GSR1 is most potently reduced when compared to inhib-
itor treatment done separately.
Involvement of p38 pathway in increasing RGS2 mRNA expres-
sion in an Sp-1 dependent manner has been reported [20]. Relevant
to this we observed that, H2O2 activated p38MAPK pathway and in-
creased Sp-1 nuclear accumulation and translocation. The p38
pathway has been reported to phosphorylate Sp-1 [21] and a Sp-1
binding site is present in mouse RGS2 promoter [20] suggesting
that Sp-1 binding to the RGS2 promoter increases its expression.
Our data supports this notion. Moreover, oxidative stress activated
PKC pathway. PKC is reported to phosphorylate RGS2 [22] and RGS2
is known to translocate to nucleus [23]. These reports are in agree-
ment with our ﬁnding of nuclear translocation of RGS2 with induc-
tion of oxidative stress. We postulate that RGS2 upon PKC
phosphorylation is shuttled to the nucleus, where it interacts with
transcription factor NF-E2-related factor (Nrf)-2, and this complex
then binds to Anti-oxidant Response Elements (ARE) present in
GLO1 and GSR1, to increase transcription. Our postulation is made
more compelling by the fact that PKC phosphorylation of Nrf2 is re-
ported to release Nrf2 from the inhibitory protein (INrf2). Nrf2 then
translocates to the nucleus, forms heterodimers with unknown pro-
teins, and activates transcription of genes containing ARE [24–26].
Whether RGS2 acts as a cofactor, an activator or a binding partner
for Nrf2 remains to be investigated. Therefore, it is reasonable to
conclude that upon induction of oxidative stress, both PKC and
p38 pathways are activated. p38 phosphorylates and activates Sp-
1. Sp-1 binds to the RGS2 promoter and activates its expression.
PKC induces nuclear translocation of RGS2 and facilitates interac-
tion with Nrf2, which induces ARE binding and promotes transcrip-
tional activation of GLO1 and GSR1.
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